Staphylococcus aureus evasion of innate antimicrobial defense

被引:62
|
作者
Kraus, Dirk [1 ]
Peschel, Andreas [1 ]
机构
[1] Univ Tubingen, Cellular & Mol Microbiol Div, Dept Med Microbiol & Hyg, D-72076 Tubingen, Germany
关键词
antimicrobial fatty acid; bacteriolytic enzyme; cationic antimicrobial peptide; innate antimicrobial defense; leukocyte recruitment; opsonization; phagocytosis; resistance mechanism; respiratory burst; Staphylococcus aureus;
D O I
10.2217/17460913.3.4.437
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacterial pathogens colonize human body surfaces soon after birth. In order to survive the constant threat of invasion and infection, the human innate immune system has evolved several efficient mechanisms to prevent harmful microorganisms from traversing epithelial barriers. These include cationic antimicrobial peptides (CAMPs) such as defensins and the cathelicidin LL-37, bacteriolytic enzymes such as lysozyme, antimicrobial fatty acids, toxic oxygen- or nitrogen-containing molecules, the bacteriolytic complement components and further mechanisms with indirect impacts on bacterial multiplication. Staphylococcus aureus is an important human commensal and pathogen. In order to successfully establish an infection, S. aureus has evolved several mechanisms to resist the innate immune system. In this review, we focus on the mechanisms employed by S. aureus to achieve protection against antimicrobial host defense molecules with special emphasis on CAMPs. Lessons from recent studies on antimicrobial host defense molecules and cognate bacterial resistance adaptation should help in the development of more sustainable anti-infective compounds.
引用
收藏
页码:437 / 451
页数:15
相关论文
共 50 条
  • [31] Keratinocytes use FPR2 to detect Staphylococcus aureus and initiate antimicrobial skin defense
    Lebtig, Marco
    Scheurer, Jasmin
    Muenkel, Marie
    Becker, Janna
    Bastounis, Effie
    Peschel, Andreas
    Kretschmer, Dorothee
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [32] Antimicrobial resistance:: the example of Staphylococcus aureus
    Lowy, FD
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (09): : 1265 - 1273
  • [33] Antimicrobial resistance in Staphylococcus aureus in Mexico
    Miranda Novales, Maria Guadalupe
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2011, 68 (04): : 242 - 249
  • [34] Antimicrobial Treatment of Staphylococcus aureus Biofilms
    Tuon, Felipe Francisco
    Suss, Paula Hansen
    Telles, Joao Paulo
    Dantas, Leticia Ramos
    Borges, Nicolas Henrique
    Ribeiro, Victoria Stadler Tasca
    ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [35] Genetics of antimicrobial resistance in Staphylococcus aureus
    Jensen, Slade O.
    Lyon, Bruce R.
    FUTURE MICROBIOLOGY, 2009, 4 (05) : 565 - 582
  • [36] Innate immunity in tuberculosis: host defense vs pathogen evasion
    Cui Hua Liu
    Haiying Liu
    Baoxue Ge
    Cellular & Molecular Immunology, 2017, 14 : 963 - 975
  • [37] Innate immunity in tuberculosis: host defense vs pathogen evasion
    Liu, Cui Hua
    Liu, Haiying
    Ge, Baoxue
    CELLULAR & MOLECULAR IMMUNOLOGY, 2017, 14 (12) : 963 - 975
  • [38] Synergistic antimicrobial effects of photodynamic antimicrobial chemotherapy and gentamicin on Staphylococcus aureus and multidrug-resistant Staphylococcus aureus
    Liu, Shupei
    Mai, Bingjie
    Jia, Mengqi
    Lin, Dewu
    Zhang, Jingdan
    Liu, Quanhong
    Wang, Pan
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2020, 30
  • [39] Staphylococcus aureus susceptibility to innate antimicrobial peptides, β-defensins and CAP18, expressed by human keratinocytes
    Midorikawa, K
    Ouhara, K
    Komatsuzawa, H
    Kawai, T
    Yamada, S
    Fujiwara, T
    Yamazaki, K
    Sayama, K
    Taubman, MA
    Kurihara, H
    Hashimoto, K
    Sugai, M
    INFECTION AND IMMUNITY, 2003, 71 (07) : 3730 - 3739
  • [40] Host Defense and Pathogenesis in Staphylococcus aureus Infections
    DeLeo, Frank R.
    Diep, Binh An
    Otto, Michael
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2009, 23 (01) : 17 - +